Skip to main content
. 2011 Sep 15;53(6):600–604. doi: 10.1093/cid/cir467

Table 1.

Demographic and Clinical Characteristics of the Sample Over Time

Calendar year
Characteristic 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Patients in care, no.a 1304 1313 1504 1582 1735 1882 1975 1965 2010 1937 1891 1930 1968 1979 1983
Age, median, years 38 38 39 40 41 41 42 43 44 45 45 46 47 48 49b
Sex, % male 71 67 66 66 66 65 65 64 64 64 64 65 65 65 65b
Race, %
    Black 73 76 76 75 74 74 74 73 73 74 74 74 74 73 73
    White 25 23 23 23 24 24 25 25 25 24 24 24 23 24 24
Transmission risk, %c
    Injection drug use 46 48 48 47 44 41 40 39 39 37 35 34 34 34 36b
    Men who have sex with men 34 31 29 30 30 29 29 28 28 28 28 28 29 28 28
    Heterosexual 43 45 45 44 47 48 48 50 50 49 49 49 51 51 51b
ZIP code, %
    Baltimore city 85 85 85 83 83 82 81 81 81 81 81 81 80 80 80
    Other Maryland 12 12 12 12 13 13 13 12 13 13 14 13 13 14 14
CD4 T-cell count, median, cells/mm3 239 290 304 296 315 328 352 340 347 377 385 406 421 435 444b
Receiving HAART, %d 22 51 58 66 69 71 70 70 75 77 79 80 83 84 85b
a

Defined as attending ≥2 clinic visits during the year.

b

P < .05 for trend from 1996 to 2010.

c

Transmission categories are not mutually exclusive.

d

HAART, highly active antiretroviral therapy.